PFE

Pfizer Inc

27.66

Sep 18 • 4:00 PM ET +0.02 (0.07%)

27.60

Aftermarket • 7:55 PM ET -0.06 (-0.22%)

Healthcare Drug Manufacturers - General USA Large NYSE

Peers: MRK LLY JNJ ABBV AZN BMY NVS AMGN SNY GSK

| Held by: VTI VOO IVV SPY VTV XLV HDV HDV VYM DVY

Index	S&P 500
Market Cap	157.65B
Enterprise Value	209.45B
Income	4.33B
Sales	63.70B
Book/sh	14.95
Cash/sh	2.05
Dividend Est.	1.72 (6.23%)
Dividend TTM	1.72 (6.22%)
Dividend Ex-Date	Jul 24, 2026
Dividend Gr. 3/5Y	2.23% 2.37%
Payout	126.85%
Employees	75000
IPO	Jan 17, 1944

P/E	36.63
Forward P/E	9.55
PEG	-
P/S	2.48
P/B	1.85
P/C	13.48
P/FCF	14.35
EV/EBITDA	8.91
EV/Sales	3.29
Quick Ratio	0.96
Current Ratio	1.27
Debt/Eq	0.74
LT Debt/Eq	0.71
Option/Short	Yes / Yes

EPS (ttm)	0.76
EPS next Y	2.90
EPS next Q	0.76
EPS this Y	-7.62%
EPS next Y	-2.62%
EPS next 5Y	-8.26%
EPS past 3/5Y	-37.19% -3.57%
Sales past 3/5Y	-14.56% 8.48%
EPS Y/Y TTM	-59.71%
Sales Y/Y TTM	-0.21%
EPS Q/Q	-108.60%
Sales Q/Q	2.60%
Earnings	Aug 04 BMO
EPS/Sales Surpr.	12.87% 4.41%

Insider Own	0.09%
Insider Trans	2.18%
Inst Own	69.78%
Inst Trans	-0.47%
ROA	2.13%
ROE	4.99%
ROIC	2.97%
Gross Margin	64.83%
Oper. Margin	26.57%
Profit Margin	6.80%
SMA20	-1.42%
SMA50	3.90%
SMA200	5.28%
Trades

Shs Outstand	5.70B
Shs Float	5.69B
Short Float	2.66%
Short Ratio	3.65
Short Interest	151.54M
52W High	29.21 -5.31%
52W Low	23.58 17.30%
Volatility	1.33% 1.70%
ATR (14)	0.51
RSI (14)	52.16
Beta	0.28
Rel Volume	1.82
Avg Volume	41.52M
Volume	75,593,422

Perf Week	-0.22%
Perf Month	-2.05%
Perf Quarter	9.72%
Perf Half Y	0.91%
Perf YTD	11.08%
Perf Year	14.53%
Perf 3Y	-17.78%
Perf 5Y	-36.98%
Perf 10Y	-14.00%
Recom	2.54
Target Price	28.57
Prev Close	27.64
Price	27.66
Change %	0.07%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-06-26	Downgrade	HSBC Securities	Buy → Hold	$28
Jun-10-26	Upgrade	RBC Capital Mkts	Underperform → Sector Perform	$25
Mar-02-26	Upgrade	Argus	Hold → Buy	$35
Feb-25-26	Initiated	RBC Capital Mkts	Underperform	$25
Feb-20-26	Initiated	Barclays	Underweight	$25
Feb-12-26	Downgrade	Daiwa Securities	Outperform → Neutral	$27
Jan-07-26	Resumed	UBS	Neutral	$25
Dec-02-25	Resumed	Citigroup	Neutral	$26
Nov-13-25	Initiated	Scotiabank	Sector Outperform	$30
Apr-22-25	Initiated	Cantor Fitzgerald	Neutral	$24
Dec-10-24	Resumed	BofA Securities	Neutral	$29
Nov-15-24	Initiated	Wolfe Research	Underperform	$25
Oct-25-24	Resumed	Citigroup	Neutral	$30
Oct-17-24	Initiated	Bernstein	Mkt Perform	$32
Aug-07-24	Upgrade	Daiwa Securities	Neutral → Outperform
Mar-22-24	Downgrade	Argus	Buy → Hold
Feb-23-24	Initiated	Guggenheim	Buy	$36
Jan-04-24	Downgrade	TD Cowen	Outperform → Market Perform	$32
Oct-20-23	Resumed	UBS	Neutral	$36 → $34
Oct-16-23	Upgrade	Jefferies	Hold → Buy	$38 → $39

Show Previous Ratings

Sep-18-26 05:23PM	What Would It Take For Eli Lilly Stock To Keep Climbing? (Trefis)
04:14PM	Is Johnson & Johnson Stock Expensive, Or Is STELARA Hiding The Real Price? (Trefis)
02:09PM	Merck Stock Nearly Doubled Without A Change In Its Revenue Growth (Trefis)
01:22PM	Trump to Announce Medicaid Drug Pricing After Pharma Deals (Barrons.com)
Sep-17-26 03:17PM	Can Volume Keep Covering Eli Lilly's Price Cuts? (Trefis)
08:11AM	Loading…
08:11AM	What Happens To AbbVie Stock If SKYRIZI Slows Down? (Trefis)
Sep-16-26 04:12PM	Is Pfizer's New Business Big Enough To Carry The Old One? (Trefis)
03:12PM	Should You Judge JNJ Stock Without STELARA? (Trefis)
Sep-15-26 08:44PM	Merck Stock: Is The $70 Billion Pipeline Worth the Premium? (Trefis)
11:18AM	Slate Medicines Names Kenneth Koblan as Chief Scientific Officer (Exec Edge)
10:00AM	Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference (Business Wire)
12:00AM	SLS, IBRX, IOVA In Focus Amid Big Pharmas Early Cancer-Asset Hunt: J&J Flags M&A Sweet Spot, Pfizer Eyes Phase 1-2 Deals (Stocktwits)
Sep-14-26 04:09PM	Is This LLY Stock Dip Big Enough To Be Worth Buying? (Trefis)
03:57PM	Why Is Pfizer Stock Paying You So Much To Wait? (Trefis)
11:26AM	IP Group eyes further value growth as cash realisations top £85m (Proactive)
03:59AM	Loading…
03:59AM	Big Pharma Is Pouring Billions Into China's Biotechs (Barrons.com)
02:02AM	AstraZeneca Breast-Cancer Drug Misses Goal in Late-Stage Trial (The Wall Street Journal)
Sep-13-26 10:39AM	Pfizer Makes an Unusual Enemy in $2 Billion Fight Over Unwanted Covid-19 Vaccines (The Wall Street Journal)
Sep-12-26 10:32AM	Medicus Pharma CEO on SkinJect and Pfizer partnership ICYMI (Proactive)
Sep-11-26 03:11PM	Is AbbVie Stock Actually Overpriced? (Trefis)
Sep-10-26 03:42PM	15 of the Highest-Yielding Dividend Stocks in the S&P 500 (Kiplinger)
02:14PM	Biohaven Stock Is Sinking. Epilepsy Drug Trial Roadblock Is Only the Latest Blow. (Barrons.com)
01:57PM	JNJ Stock: Is the Rally Running Out of Steam? (Trefis)
01:05PM	Pfizer Stock Or Zoetis: Is The Comeback Worth Paying Up For? (Trefis)
11:58AM	Medicus Pharma secures Pfizer ADC deal, advances SkinJect and precision oncology strategy (Proactive)
11:05AM	Why Has AbbVie Gone Quiet About Humira? (Trefis)
Sep-09-26 10:32PM	Amgen's Forward Multiple Looks Cheap Until You Price The Margins It Assumes (Trefis)
04:41PM	What Eli Lilly Was Telling You While It Rationed Its Own Launches (Trefis)
11:46AM	VERAXA Biotech Designates Raju Willener as CFO (Exec Edge)
Sep-08-26 01:08PM	Is AbbVie Stock Too Reliant On Skyrizi? (Trefis)
10:36AM	Loading…
10:36AM	What Merck Stopped Saying About GARDASIL Should Change What You Watch (Trefis)
10:00AM	Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference (Business Wire)
08:53AM	Medicus Pharma Prioritises CD228V Oncology Programme in Development Strategy (InvestorsHub)
05:39AM	Novartis India acquires Pfizer brands for $132m (Pharmaceutical Business Review)
Sep-04-26 12:57PM	Was JNJ Stock Rally Actually Its Own? (Trefis)
08:00AM	Trailing rivals, AbbVie scores win with dual-acting myeloma drug (BioPharma Dive)
05:00AM	Ionis rare neurology drug approved; Pfizer inks an ADC deal (BioPharma Dive)
Sep-03-26 12:07PM	Is Merck Stock Pricing In A Post-Keytruda Future Too Soon? (Trefis)
12:00PM	Summit Therapeutics Says It Is Beating Merck With Its Cancer Drug (Barrons.com)
11:54AM	ABBV Stock Has Returned $62 Billion To Shareholders. Should You Care? (Trefis)
11:24AM	Is Johnson & Johnson Stock Priced For More Growth Than It Has Guided? (Trefis)
12:51AM	Why Did PFE, GTLB, COP Stocks Jump To 52-Week Highs Today? (Stocktwits)
Sep-02-26 04:55PM	Amgen Stock Signals Its Confidence. The Market Agrees. (Trefis)
02:19PM	Can AI Save Pfizer Stock Before Its Patent Cliff Hits? (Trefis)
01:16PM	How Did Merck Stock Beat The Market With Slowing Sales? (Trefis)
03:26AM	What to Watch: Nikes Q1 Report Will See Investors Focus on What the New CFO Says (Footwear News)
Sep-01-26 10:51PM	Why Did PFE, MMED, DE Stocks Surge To 52-Week Highs Today? (Stocktwits)
Aug-28-26 03:09PM	Did A Product Swap Fuel JNJ Stocks 54% Surge? (Trefis)
02:35PM	Can Merck Stock Outrun Its Pipeline? (Trefis)
01:58PM	Pfizer's Updated COVID Shot Ships Into a Smaller Market (GuruFocus.com)
08:54AM	Alnylam stock drops on rival heart trial: Why analysts see core business safe (Investing.com)
07:59AM	Moderna raises $2.6B to support cancer work; FDA clears updated COVID vaccines (BioPharma Dive)
Aug-27-26 08:19PM	Amgen Stock Signals Its Confidence. The Market Agrees. (Trefis)
05:49PM	Slate Medicines Starts Migraine Treatment Study (Exec Edge)
04:30PM	Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine (Business Wire)
01:01PM	Is Merck Stock Reaching A Valuation Ceiling At 6x Sales? (Trefis)
10:25AM	Can Cost Cuts And 2030 Targets Really Save Pfizer Stock? (Trefis)
Aug-26-26 03:41PM	Has AbbVie Stock Become Too Expensive to Buy? (Trefis)
03:31PM	How Much Upside Is Left in JNJ Stock? (Trefis)
11:13AM	Moderna Stock Carries A Market Value Its Revenue Does Not Support (Trefis)
09:33AM	Can Eli Lilly Stock Keep Surging As Drug Prices Fall? (Trefis)
07:40AM	Metsera backers establish new biotech armed with China-licensed immunology asset (Pharmaceutical Technology)
Aug-25-26 01:58PM	Eli Lilly Found a New Gear. You Paid For It. (Trefis)
Aug-24-26 07:35PM	Eli Lilly Stock Raised Its Forecast, So Why Is The Market Shrugging? (Trefis)
03:01PM	Moderna Stock Had A Readout Waiting In Plain Sight (Trefis)
02:36PM	Exelixis Owners Keep Getting A Bigger Slice Of A Company In Transition (Trefis)
02:02PM	Snoring, subways and stealth ads: how big pharma targets China's waistline (Reuters)
Aug-21-26 02:54PM	Can mRNA Cure Cancer? Inside the Pipeline Risks for Biotech's Biggest Players (Barrons.com)
02:40PM	Lilly's Multiple Assumes Less Growth Than You Think (Trefis)
01:48PM	Most Of What Moves AbbVie Stock Has Nothing To Do With The Market (Trefis)
01:44PM	Why Moderna's mRNA Cancer Drug Hype Has Gone Too Far (Barrons.com)
08:08AM	Pharma Stocks Have Rallied. 2 Stocks to Avoid-and 2 to Buy. (Barrons.com)
Aug-20-26 02:21PM	Moderna's Melanoma Result Landed On A Market Positioned The Other Way (Trefis)
01:27PM	Merck Stock Ran On A Checklist Published In Advance (Trefis)
12:54PM	Pfizer Stock Is A Race Between New Drugs And Old Patents (Trefis)
10:58AM	What Moderna & Merck's cancer vaccine breakthrough means for healthcare stocks (Yahoo Finance Video)
05:59AM	Why Is Merck Stock Still Undervalued After An 80% Surge? (Trefis)
Aug-19-26 04:08PM	Johnson & Johnson Stock Runs On A Calendar The Market Does Not Set (Trefis)
03:40PM	Is AbbVie Stock About To Break Out Again? (Trefis)
02:54PM	BioNTech Stock Surges 20% on Moderna Cancer Vaccine Win. Why the Gains Could Fade. (Barrons.com)
01:02PM	Why 2026 Is Biotech's Comeback Year (Barrons.com)
12:00PM	Flash Heard: Why Healthcare Is Partying Like It's Late 2020 (The Wall Street Journal)
11:15AM	Insider Watch: 3 CEOs Betting Millions on Their Own Stocks (Zacks)
06:30AM	HEALWELL AI's DARWEN(TM) AI Platform Nominated for 2026 International Prix Galien, the Global "Best of the Best" in Life Sciences Innovation (TMX Newsfile)
05:24AM	Obesity investings way forward, mapped (Pitchbook)
Aug-18-26 10:27AM	Nike Stock Hits Lowest Level Since 2014 as Turnaround Drags On (Barrons.com)
Aug-17-26 05:29PM	Why Isn't Eli Lilly Stock Trading At The Top Of Its Peer Group? (Trefis)
12:11PM	Fulcrum Therapeutics & Slate Medicines Merge for Next-Generation Migraine Therapies (Exec Edge)
11:28AM	What The Headline Growth Rate Hides About JNJ Stock (Trefis)
06:07AM	EMA validates Pfizer and Valneva's Lyme disease vaccine (Pharmaceutical Business Review)
Aug-14-26 05:22PM	AbbVie Defends Its Turf, But Leaves One Big Question Open (Trefis)
01:45PM	Pfizer CEO Caps Post-Earnings Insider Buying Spree With $1 Million Stock Purchase (Barrons.com)
11:54AM	Why Did VALN Stock Surge 24% Today? (Stocktwits)
04:59AM	BioNTechs oncology pivot comes with a new CEO (Pharma Voice)
01:00AM	Pfizer and Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency (Business Wire)
Aug-13-26 12:10PM	The Sharpest Exchanges From ABBV's Earnings Call (Trefis)
08:20AM	Pfizer CEO Buys $1 Million of Stock (GuruFocus.com)
01:01AM	Spero Therapeutics Inc (SPRO) (Q2 2026) Earnings Call Highlights: FDA Approval of Utebzi and ... (GuruFocus.com)
Aug-12-26 04:49PM	How ABBV Stock Moved Away From Its Peer Group (Trefis)
03:17PM	Amgen Stock And The Price Of A Promise (Trefis)

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Ph.D.Dr. Albert Bourla D.V.M.

M.D.Dr. Chris Boshoff FMedSci

Executive VP & Chief Legal OfficerMr. Douglas M. Lankler

Executive VP & Chief U.S. Commercial OfficerMr. Aamir Malik

Interim CFO & Executive VPMs. Cecile Guegan

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BOURLA ALBERT	Chairman & CEO	Aug 12 '26	Buy	26.34	38,000	1,000,920	429,173	Aug 12 04:04 PM
DAMICO JENNIFER B.	SVP & Controller	Aug 05 '26	Sale	25.40	3,278	83,261	28,611	Aug 06 11:26 AM
BLAYLOCK RONALD E	Director	Aug 05 '26	Buy	25.46	39,231	998,821	66,938	Aug 05 04:03 PM
Buckley Mortimer J	Director	Aug 05 '26	Buy	25.52	37,632	960,369	37,632	Aug 05 04:02 PM
DAMICO JENNIFER B.	SVP & Controller	Jun 09 '26	Sale	25.70	2,000	51,400	31,397	Jun 10 07:58 PM
SAHNI PAYAL	Executive Vice President	Feb 25 '26	Option Exercise	33.82	56,888	1,923,952	82,816	Feb 27 06:35 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 25 '26	Option Exercise	33.82	122,907	4,156,715	282,186	Feb 27 06:35 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 25 '26	Option Exercise	33.82	17,558	593,812	29,744	Feb 27 06:35 PM
BOURLA ALBERT	Chairman & CEO	Feb 25 '26	Option Exercise	33.82	491,626	16,626,791	864,215	Feb 27 06:34 PM
Fonseca Lidia	Executive Vice President	Feb 25 '26	Option Exercise	33.82	56,888	1,923,952	101,579	Feb 27 06:34 PM
McDermott Michael	Executive Vice President	Feb 25 '26	Option Exercise	33.82	37,925	1,282,624	114,534	Feb 27 06:34 PM

Open in Screener

KMX

Carmax Inc

57.21

Sep 18 • 3:59 PM ET -1.17 (-2.00%)

57.21

Aftermarket • 7:30 PM ET +0.00 (0.00%)

Consumer Cyclical Auto & Truck Dealerships USA Mid NYSE

Peers: CVNA AN CARG LAD GPI PAG SAH LKQ AAP AZO

| Held by: IJR VTI VB AVUV VXF VBR SPSM IJS RWJ SLYV

Index	-
Market Cap	8.12B
Enterprise Value	26.22B
Income	222.54M
Sales	28.19B
Book/sh	43.12
Cash/sh	5.13
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	27796
IPO	Feb 04, 1997

P/E	37.65
Forward P/E	-
PEG	-
P/S	0.29
P/B	1.33
P/C	11.16
P/FCF	8.17
EV/EBITDA	27.36
EV/Sales	0.93
Quick Ratio	0.82
Current Ratio	2.70
Debt/Eq	3.08
LT Debt/Eq	2.97
Option/Short	Yes / Yes

EPS (ttm)	1.52
EPS next Y	-
EPS next Q	0.72
EPS this Y	-7.16%
EPS next Y	-
EPS next 5Y	1.68%
EPS past 3/5Y	-17.96% -18.02%
Sales past 3/5Y	-3.76% 6.67%
EPS Y/Y TTM	-58.01%
Sales Y/Y TTM	-1.69%
EPS Q/Q	-5.27%
Sales Q/Q	5.51%
Earnings	Sep 29 BMO
EPS/Sales Surpr.	35.71% 7.94%

Insider Own	2.04%
Insider Trans	0.84%
Inst Own	102.99%
Inst Trans	-6.32%
ROA	0.82%
ROE	3.59%
ROIC	0.92%
Gross Margin	10.68%
Oper. Margin	2.06%
Profit Margin	0.79%
SMA20	-6.68%
SMA50	-3.53%
SMA200	20.83%
Trades

Shs Outstand	141.91M
Shs Float	139.02M
Short Float	8.05%
Short Ratio	4.66
Short Interest	11.19M
52W High	65.28 -12.36%
52W Low	30.26 89.06%
Volatility	3.24% 2.99%
ATR (14)	1.89
RSI (14)	38.54
Beta	1.22
Rel Volume	1.75
Avg Volume	2.40M
Volume	4,206,960

Perf Week	-6.70%
Perf Month	-2.95%
Perf Quarter	6.62%
Perf Half Y	34.99%
Perf YTD	48.06%
Perf Year	-4.65%
Perf 3Y	-30.58%
Perf 5Y	-59.22%
Perf 10Y	1.26%
Recom	2.85
Target Price	52.25
Prev Close	58.38
Price	57.21
Change %	-2.00%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-29-26	Upgrade	JP Morgan	Underweight → Neutral	$60
Jul-21-26	Upgrade	Barclays	Underweight → Equal Weight	$61
Jun-18-26	Upgrade	Stephens	Equal-Weight → Overweight	$66
May-27-26	Initiated	UBS	Neutral	$42
Apr-15-26	Resumed	BofA Securities	Underperform	$40
Nov-12-25	Initiated	Barclays	Underweight	$28
Nov-10-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$35
Nov-07-25	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Nov-07-25	Downgrade	Needham	Buy → Hold
Nov-06-25	Downgrade	William Blair	Outperform → Mkt Perform
Nov-06-25	Downgrade	The Benchmark Company	Buy → Hold
Nov-06-25	Downgrade	JP Morgan	Neutral → Underweight	$30
Oct-07-25	Downgrade	Stephens	Overweight → Equal-Weight	$42
Sep-29-25	Downgrade	Seaport Research Partners	Buy → Neutral
Sep-26-25	Downgrade	Oppenheimer	Outperform → Perform
Sep-26-25	Downgrade	Evercore ISI	Outperform → In-line	$52
Sep-25-25	Downgrade	Wedbush	Outperform → Neutral
Aug-06-25	Upgrade	JP Morgan	Underweight → Neutral	$58
Jul-17-25	Initiated	The Benchmark Company	Buy	$75
Jul-01-25	Resumed	Morgan Stanley	Overweight	$80

Show Previous Ratings

Sep-18-26 01:16PM	Should You Buy Copart Stock On The ACV Deal? (Trefis)
Sep-09-26 05:00PM	CarMax Announces Second Quarter Conference Call (Business Wire)
Aug-27-26 01:31AM	No AI, No Problem: 5 Consumer Stocks Quietly Outperforming Nvidia This Year (Stocktwits)
Aug-25-26 08:30AM	Gen Alpha Turns 16: New CarMax Survey Reveals the Next Generation of Drivers Is Ready to Get Behind the Wheel (GlobeNewswire)
Aug-12-26 09:45AM	CarMax Named one of the 2026 PEOPLE Companies That Care (GlobeNewswire)
09:36PM	Loading…
Aug-06-26 09:36PM	The Takeover Case for OPLN: A Digital Powerhouse Hiding in Plain Sight (Trefis)
09:30AM	CarMax Teams with Sierra to Enhance Inbound Sales Call Experience (GlobeNewswire)
Aug-05-26 12:23PM	Starboard Value Has Taken New Position in Shake Shack (Bloomberg)
Jul-29-26 05:16PM	JPMorgan Delivers Major CarMax Stock Reset (GuruFocus.com)
Jul-02-26 12:43PM	CarMax's Turnaround Is a Work in Progress, but Insiders Are Buying Anyway (Barrons.com)
Jun-30-26 10:00AM	CarMax Recognized as One of the 50 Most Community-Minded Companies in the US (GlobeNewswire)
Jun-26-26 07:00AM	For CarMax, lower profits are part of its short-term growth strategy (Wards Auto)
Jun-18-26 06:54PM	The Price Of A CarMax Sales Beat (Trefis) +13.14%
01:29PM	KMX Stock Recoups Earnings Day Losses Analysts Pour Praise On New CarMax CEOs Focus On Cost And Customer Experience (Stocktwits)
09:02AM	CarMax Q1 FY2027 earnings beat: Keith Barr unveils growth strategy (Quartz)
09:02AM	Loading…
09:02AM	CarMax beat earnings estimates but is facing falling used-car margins as new CEO unveils growth strategy (Quartz)
Jun-17-26 04:43PM	CarMax Earnings Fall Far Less Than Feared, But Shares Sink (Investor's Business Daily) -8.98%
03:01PM	KMX Stock Slides Nearly 9% CarMax CEO Flags Operational Challenges, Says Costs Are Too High (Stocktwits)
03:00PM	CarMax Inc (KMX) Q1 2027 Earnings Call Highlights: Strong Sales Growth Amidst Profitability ... (GuruFocus.com)
11:09AM	?? Under the Radar: CarMax Stock Slides as CEO Flags Challenges (The Wall Street Journal)
10:34AM	CarMax shares drop as margin pressure overshadows strong quarterly results (Proactive)
10:12AM	Options Traders Circle CarMax Stock After Post-Earnings Pivot (Schaeffer's Research)
08:45AM	CarMax Tops Expectations as Growth Plan Gains Momentum (KMX) (InvestorsHub)
06:48AM	CarMax beats estimates as new strategy drives early results (Investing.com)
06:38AM	CarMax Profit Falls Despite Higher Sales (The Wall Street Journal)
06:37AM	CarMax Stock Rises. Used-Car Retailer Tops Earnings Estimates. (Barrons.com)
06:05AM	CarMax: Fiscal Q1 Earnings Snapshot (Associated Press)
05:50AM	CarMax Reports First Quarter Fiscal 2027 Results (Business Wire)
Jun-14-26 02:00PM	The FOMC Meeting, Retail Sales Data, Kroger Earnings, and More to Watch This Week (Barrons.com)
May-28-26 05:00PM	CarMax Announces First Quarter Conference Call and Annual Meeting Information (Business Wire)
09:35AM	Loading…
May-27-26 09:35AM	FedEx upgraded, Dollar General downgraded: Wall Street's top analyst calls (The Fly)
May-12-26 04:40PM	CarMax Announces Robert O'Shaughnessy to Join Board of Directors (Business Wire)
May-08-26 10:43AM	Will Carvana Continue To Rally Post Stock Split? (Trefis)
Apr-17-26 08:13AM	CarMax prices start to fall as turnaround plan begins (Wards Auto)
Apr-15-26 09:47AM	Cloudflare upgraded, SolarEdge downgraded: Wall Street's top analyst calls (The Fly)
08:00AM	CarMax cut its prices to bring back buyers. It just reported a $121 million loss (Moneywise)
03:01AM	CarMax Inc (KMX) Q4 2026 Earnings Call Highlights: Navigating Challenges with Strategic Adjustments (GuruFocus.com)
Apr-14-26 04:46PM	CarMax, Inc. Q4 2026 Earnings Call Summary (Moby) -15.12%
02:10PM	Tesla stock upgraded, CarMax Q4 earnings disappoint Wall Street (Yahoo Finance Video)
01:23PM	Why CarMax Stock Is Sinking Despite Earnings Beat (Investor's Business Daily)
12:44PM	CarMax Shares Drop 12% As Profit Per Vehicle Set To Decline (GuruFocus.com)
11:11AM	CarMax Drops as Investors Underwhelmed by Revival Strategy (Bloomberg)
07:32AM	CarMax beats FQ4 forecasts, flags $141mn goodwill charge; shares dip (Investing.com)
07:23AM	CarMax Swings to Loss After Cutting Prices to Bring Back Shoppers (The Wall Street Journal)
07:09AM	CarMax: Fiscal Q4 Earnings Snapshot (Associated Press)
07:04AM	CarMax Stock Sinks After Earnings. New CEO Has Work to Do. (Barrons.com)
06:50AM	CarMax Reports Fourth Quarter and Fiscal Year 2026 Results (Business Wire)
06:00AM	Morning Brief: Goldman rakes it in, but issues a warning (Yahoo Finance)
04:57AM	JPMorgan, Citi and Wells Fargo deliver results as earnings season gathers speed (MarketWatch)
04:11AM	Stock Market Today: Dow, S&P 500 and Nasdaq set to hold near record highs as earnings season ramps up with JPMorgan results on tap (MarketWatch)
Apr-09-26 04:51PM	CarMax Will Add Two Board Members After Talks With Activist Investor Starboard (The Wall Street Journal)
04:15PM	CarMax Announces William Cobb and Jim Kessler to Join the Board (Business Wire)
Apr-06-26 11:16AM	Carvana Stock Doubled Last Year. Why This Analyst Isn't Bullish Anymore. (Barrons.com)
Apr-01-26 09:30AM	CARMAX CELEBRATES 22nd CONSECUTIVE YEAR AS ONE OF FORTUNE MAGAZINE'S 100 BEST COMPANIES TO WORK FOR (GlobeNewswire)
Mar-27-26 07:15AM	New CarMax CEO Barr looks to tech for better UX (Wards Auto)
Mar-26-26 04:37PM	Stock traders are wary of this market - and retail investors should be too (MarketWatch)
Mar-19-26 05:00PM	CarMax Announces Fourth Quarter Conference Call (Business Wire)
04:12PM	These charts suggest the bears aren't done with the stock market yet (MarketWatch)
Mar-18-26 11:45AM	CarMax appoints Keith Barr as CEO (Wards Auto)
Mar-13-26 08:44PM	Oracle Has More Resilience Amid AI Pressures, Says Analyst. Plus, CarMax, Rivian, and More Stocks. (Barrons.com)
Mar-12-26 06:40PM	The S&P 500 just broke a major support. Another 10% decline is likely. (MarketWatch)
Mar-11-26 04:20PM	Investor Starboard Sees CarMax Upside as Barr Takes Helm (Transport Topics)
02:30PM	Starboard Builds $350 Million Stake in CarMax, Seeks Board Seats (GuruFocus.com)
01:40PM	Starboard Takes $350 Million CarMax Stake, Seeks Board Seats (Bloomberg)
01:01PM	An Important Investor Has an Idea for CarMax: Charge Less for Used Cars (Investopedia)
11:29AM	Falling prices steer US buyers toward used electric vehicles (Reuters)
10:35AM	CarMax Issues Statement on Engagement With Starboard Value (Business Wire)
09:58AM	CarMax Stock Edges Higher as Activist Takes Stake, Says New CEO Must 'Move Quickly' (Barrons.com)
09:34AM	Activist Starboard Pushes for Change at CarMax (The Wall Street Journal)
09:17AM	CarMax Stock: Auto Business Activist Investor Takes Stake (Investor's Business Daily)
08:00AM	Starboard Delivers Letter to CarMax (Business Wire)
Mar-06-26 10:02AM	Will Carvana's Fixed Cost Leverage Drive Its EBITDA Margin? (Zacks)
09:52AM	Will Vertical Integration Strengthen Carvana's Prospects? (Zacks)
Mar-05-26 08:03AM	Carvana's Rough Start to 2026 Post Stellar 2025: How to Play the Stock (Zacks)
Mar-04-26 08:10AM	GM merging its CPO dealer sales program with CarBravo (Wards Auto)
Mar-03-26 09:40AM	Should Value Investors Buy CarMax (KMX) Stock? (Zacks)
Feb-27-26 10:36AM	CarMax Launches First-of-Its-Kind Car Shopping and Selling Experience in ChatGPT App Store (GlobeNewswire)
Feb-26-26 10:33PM	Q4 Earnings Recap: CarMax (NYSE:KMX) Tops Vehicle Retailer Stocks (StockStory)
Feb-25-26 10:10AM	Trump Trade: FedEx files suit to recoup tariff duties (TipRanks)
Feb-23-26 07:45PM	CarMax to pay $420K to resolve DOJ allegations over servicemember vehicle repossessions (Fox Business)
Feb-19-26 08:12PM	CarGurus Q4 Earnings Call Highlights (MarketBeat)
Feb-18-26 12:25PM	Why Is CarMax (KMX) Stock Soaring Today (StockStory) +8.05%
Feb-14-26 02:26PM	Carvana Drops 15% This Week: Heres The 3 Biggest Storylines (24/7 Wall St.)
Feb-13-26 08:56AM	$1 Billion Accounting Questions Cloud Carvanas 44% Sales Surge (24/7 Wall St.)
Feb-12-26 09:43AM	CarMax Taps Former Hotel CEO Keith Barr After Sales Slump (Transport Topics) -10.57%
09:00AM	Wallace Weitz Exits CarMax Inc, Impacting Portfolio by -1.58% (GuruFocus.com)
09:00AM	Eclipse backs all-EV marketplace Ever in $31M funding round (TechCrunch)
07:36AM	CarMax Names a New CEO. He's Not a Car Guy. (Barrons.com)
06:50AM	CarMax Names Keith Barr as Chief Executive Officer (Business Wire)
06:20AM	CarMax Taps Hotel Veteran to Lead Turnaround (The Wall Street Journal)
Feb-08-26 11:41PM	1 Safe-and-Steady Stock Worth Investigating and 2 We Question (StockStory)
Feb-04-26 07:30AM	CarMax Named One of TIME's America's Most Iconic Companies (GlobeNewswire)
05:44AM	CarMax, Inc. (KMX) Turns to Pricing and Marketing Actions to Revitalize Sales (Insider Monkey)
Feb-03-26 11:35PM	1 Profitable Stock to Target This Week and 2 We Turn Down (StockStory)
Jan-30-26 09:24AM	Giverny Capital Asset Management Exited Its Long-Term Holding CarMax (KMX) in 2025 (Insider Monkey)
Jan-23-26 08:56AM	Should You Hold CarMax (KMX)? (Insider Monkey)
Jan-14-26 07:50AM	CarGurus Pivots Beyond Marketplace at Needham Conference, Ramping AI and Dealer Software Push (MarketBeat)
Jan-13-26 11:05PM	3 Reasons KMX is Risky and 1 Stock to Buy Instead (StockStory)
Jan-12-26 11:43AM	Why CarMax Stock Slipped 53% In 2025 (Motley Fool)
Jan-07-26 05:59AM	CarMax promises price relief for used-car customers (Wards Auto) +5.35%

CarMax, Inc.is a holding company, which engages in the retail sale of used vehicles and wholesale vehicle sales. It operates through the following segments: CarMax Sales Operations, and CarMax Auto Finance (CAF) segments. The CarMax Sales Operations segment consists of retail sales of used vehicles, wholesale vehicle sales, related products and services, vehicle repair services, and financing arrangements. The CAF segment consists of its finance operation, which provides financing to customers purchasing retail vehicles from CarMax. The company was founded by Richard L. Sharp and William Austin Ligon in 1993 and is headquartered in Richmond, VA.

Executive VPMr. Enrique N. Mayor-Mora

Executive VP & COOMr. Charles Joseph Wilson

Executive VP and Chief Information & Technology OfficerMr. Shamim Mohammad CPA

Executive VPMs. Diane Long Cafritz J.D.

CEOMr. Keith Barr

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Chawla Sona	Director	Jun 25 '26	Buy	53.39	2,000	106,780	21,702	Jun 26 04:13 PM
Shinder Marcella	Director	Jun 25 '26	Buy	52.01	574	29,854	24,993	Jun 26 04:13 PM
ONeil Mark F	Director	Jun 24 '26	Buy	52.36	4,800	251,328	4,800	Jun 26 04:13 PM
ONeil Mark F	Director	Jun 24 '26	Buy	52.36	4,800	251,328	29,490	Jun 26 04:13 PM
FOLLIARD THOMAS J	Director	Jun 23 '26	Option Exercise	51.91	14,855	771,123	227,676	Jun 24 05:21 PM
Bensen Peter J	Director	Jun 22 '26	Buy	52.20	2,500	130,500	24,796	Jun 24 05:21 PM
Barr Keith	President and CEO	Jun 22 '26	Buy	53.01	9,400	498,247	33,375	Jun 24 05:20 PM
McCreight David W.	Director	Mar 16 '26	Option Exercise	41.71	30,558	1,274,574	47,257	Mar 18 04:11 PM
ONeil Mark F	Director	Oct 02 '25	Buy	46.21	10,816	499,807	24,690	Oct 06 04:11 PM
STEENROD MITCHELL D	Director	Oct 02 '25	Buy	45.57	2,000	91,140	38,330	Oct 03 04:09 PM

PFE

Pfizer Inc

KMX

Carmax Inc

Upgrade your Finviz experience